Erschienen in:
01.08.2011 | Commentary
In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
verfasst von:
Mehmet Birhan Yilmaz, Alexandre Mebazaa
Erschienen in:
Critical Care
|
Ausgabe 4/2011
Einloggen, um Zugang zu erhalten
Abstract
Levosimendan, in addition to its inotropic properties, could have anti-inflammatory and anti-oxidative properties, and can potentially decrease the deleterious effects of reactive oxygen species on the tissues. In their study, Hasslacher and colleagues provided not only in vitro but also in vivo evidence that levosimendan could preserve organ function in acute heart failure and septic-shock-induced myocardial depression via cooling down the oxidative burst of circulating cells.